| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,384 |
11,483 |
$813K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,509 |
7,352 |
$375K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,205 |
3,708 |
$289K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,942 |
2,484 |
$264K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
5,618 |
4,867 |
$170K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,824 |
1,534 |
$79K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,752 |
3,157 |
$75K |
| 99051 |
|
4,913 |
4,386 |
$70K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,025 |
1,674 |
$62K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,100 |
1,856 |
$61K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,364 |
4,730 |
$55K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,588 |
3,751 |
$53K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,741 |
6,679 |
$45K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
400 |
358 |
$31K |
| 36415 |
Collection of venous blood by venipuncture |
9,425 |
7,935 |
$15K |
| 99487 |
Ccm add 20min |
945 |
911 |
$14K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
349 |
284 |
$13K |
| 81003 |
|
8,130 |
6,957 |
$12K |
| 81025 |
|
2,000 |
1,733 |
$10K |
| 71046 |
Radiologic examination, chest; 2 views |
439 |
359 |
$6K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,383 |
1,157 |
$6K |
| 80053 |
Comprehensive metabolic panel |
834 |
731 |
$5K |
| 92551 |
|
958 |
818 |
$5K |
| 86308 |
|
940 |
827 |
$4K |
| 80061 |
Lipid panel |
499 |
443 |
$4K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
56 |
52 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
269 |
246 |
$3K |
| 82962 |
|
1,481 |
1,270 |
$3K |
| 90686 |
|
210 |
193 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
247 |
196 |
$2K |
| 99173 |
|
924 |
794 |
$2K |
| 87210 |
|
446 |
391 |
$2K |
| 99384 |
|
17 |
12 |
$1K |
| 87220 |
|
423 |
374 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
221 |
194 |
$1K |
| 99490 |
Ccm add 20min |
197 |
191 |
$1K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
12 |
12 |
$1K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
334 |
271 |
$1K |
| 82947 |
|
421 |
364 |
$1K |
| 93000 |
|
92 |
77 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
93 |
82 |
$946.40 |
| 99215 |
Prolong outpt/office vis |
13 |
12 |
$906.35 |
| 3008F |
|
618 |
502 |
$860.98 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,732 |
1,458 |
$590.85 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
409 |
335 |
$557.10 |
| 99443 |
|
29 |
18 |
$500.97 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
207 |
170 |
$223.87 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
33 |
30 |
$160.09 |
| 1160F |
|
212 |
171 |
$151.48 |
| 1159F |
|
212 |
171 |
$151.47 |
| 86318 |
|
13 |
12 |
$143.83 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
14 |
14 |
$136.45 |
| 1125F |
|
14 |
12 |
$80.00 |
| 99489 |
Ccm add 20min |
372 |
350 |
$77.84 |
| 3077F |
|
375 |
317 |
$70.00 |
| 3074F |
|
334 |
278 |
$50.00 |
| 3078F |
|
374 |
328 |
$50.00 |
| 3080F |
|
331 |
277 |
$20.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
6,810 |
5,531 |
$10.34 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
98 |
78 |
$1.08 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
1,468 |
1,221 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
656 |
526 |
$0.00 |
| 1036F |
|
2,383 |
1,932 |
$0.00 |
| 3079F |
|
89 |
68 |
$0.00 |
| 3044F |
|
15 |
12 |
$0.00 |
| 3075F |
|
13 |
12 |
$0.00 |
| G8484 |
Influenza immunization was not administered, reason not given |
238 |
215 |
$0.00 |
| 4004F |
|
205 |
165 |
$0.00 |
| G8731 |
Pain assessment using a standardized tool is documented as negative, no follow-up plan required |
34 |
25 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
67 |
58 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
340 |
303 |
$0.00 |